Arca
Skip to content
Tools
Tools

HBB: Hemoglobin subunit beta

Involved in oxygen transport from the lung to the various peripheral tissues. .

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on HBB, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Other 2

Approved2

  • Betibeglogene autotemcel
  • Lovotibeglogene autotemcel

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        Betibeglogene autotemcelApprovedGenetix Biotherapeutics Inc.GeneExogenous geneHemoglobin beta chain exogenous gene1
        Lovotibeglogene autotemcelBoxed warningApprovedGenetix Biotherapeutics Inc.GeneExogenous geneHemoglobin beta chain exogenous gene1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 2 in all, from ClinicalTrials.gov.
        A Study of Participants with Β-Thalassemia Treated with Betibeglogene AutotemcelBetibeglogene autotemcel—RecruitingGenetix Biotherapeutics Inc.Feb 21, 2024
        A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell DiseaseLovotibeglogene autotemcelPhase 3Active, not recruitingGenetix Biotherapeutics Inc.Mar 3, 2020

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Dominant beta-thalassemia0.79
        • Hemoglobin M disease0.77
        • Beta-thalassemia HBB/LCRB0.77
        • Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome0.76
        • Erythrocytosis, familial, 60.75
        • Heinz body anemia0.73

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4331, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P68871, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.